Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSTR
2726
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $6.8M | ﹤0.01% |
331,975
+54,506
| +20% | +$1.1M |
|
2727
Cartesian Therapeutics
RNAC
$231M
| $6.78M | ﹤0.01% |
54,075
+7,450
| +16% | +$887K |
|
2728
Blue Bird Corp
BLBD
$2.36B
| $6.76M | ﹤0.01% |
272,114
+3,593
| +1% | +$94.5K |
|
|
TA
2729
DELISTED
TravelCenters of America LLC
TA
| $6.76M | ﹤0.01% |
231,240
+106,400
| +85% | +$2.96M |
|
2730
Sierra Bancorp
BSRR
$524M
| $6.74M | ﹤0.01% |
264,874
+9,365
| +4% | +$253K |
|
2731
Descartes Systems
DSGX
$6.56B
| $6.73M | ﹤0.01% |
96,938
+3,273
| +3% | +$207K |
|
|
OLO
2732
DELISTED
Olo Inc
OLO
| $6.72M | ﹤0.01% |
+179,756
| New | +$5.71M |
|
2733
Treace Medical Concepts
TMCI
$304M
| $6.72M | ﹤0.01% |
+214,993
| New | +$6.84M |
|
|
GOLD
2734
Gold.com Inc
GOLD
$1.22B
| $6.72M | ﹤0.01% |
288,984
+113,330
| +65% | +$2.53M |
|
2735
Oportun Financial
OPRT
$267M
| $6.7M | ﹤0.01% |
334,313
+14,925
| +5% | +$306K |
|
2736
UFP Technologies
UFPT
$2.07B
| $6.7M | ﹤0.01% |
116,625
+2,799
| +2% | +$152K |
|
2737
Bristow Group
VTOL
$1.35B
| $6.69M | ﹤0.01% |
261,379
+4,220
| +2% | +$114K |
|
2738
Lineage Cell Therapeutics
LCTX
$277M
| $6.66M | ﹤0.01% |
2,338,584
+1,072,633
| +85% | +$2.78M |
|
2739
Citius Pharmaceuticals
CTXR
$16.4M
| $6.63M | ﹤0.01% |
76,220
+42,052
| +123% | +$2.53M |
|
2740
Bank of Marin Bancorp
BMRC
$474M
| $6.61M | ﹤0.01% |
207,289
-3,955
| -2% | -$138K |
|
2741
Quantum Corp
QMCO
$416M
| $6.6M | ﹤0.01% |
47,877
+7,040
| +17% | +$1.14M |
|
|
POSH
2742
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $6.57M | ﹤0.01% |
137,715
+80,886
| +142% | +$3.47M |
|
|
ZOM
2743
DELISTED
Zomedica Corp.
ZOM
| $6.56M | ﹤0.01% |
7,881,629
+447,236
| +6% | +$417K |
|
|
ZIXI
2744
DELISTED
Zix Corporation
ZIXI
| $6.54M | ﹤0.01% |
928,446
+12,311
| +1% | +$89.1K |
|
|
AWH
2745
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $6.54M | ﹤0.01% |
77,591
-3,995
| -5% | -$343K |
|
|
ICAD
2746
DELISTED
iCAD Inc
ICAD
| $6.53M | ﹤0.01% |
377,207
+34,083
| +10% | +$598K |
|
2747
Cadiz
CDZI
$260M
| $6.51M | ﹤0.01% |
478,991
+20,397
| +4% | +$244K |
|
|
EVLO
2748
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $6.49M | ﹤0.01% |
23,607
+4,320
| +22% | +$1.09M |
|
2749
Comscore
SCOR
$108M
| $6.48M | ﹤0.01% |
64,806
+12,826
| +25% | +$1.01M |
|
|
BNFT
2750
DELISTED
Benefitfocus, Inc.
BNFT
| $6.46M | ﹤0.01% |
458,241
-11,593
| -2% | -$164K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.